[Fluoroquinolone susceptibility of Pseudomonas aeruginosa strains isolated from clinical materials]

Zenobia Wydmuch1, Jerzy Pacha, Małgorzata Kepa

  • 1Katedra i Zakład Mikrobiologii Wydziału Farmaceutycznego SAM w Sosnowcu.

Medycyna Doswiadczalna I Mikrobiologia
|October 28, 2003
PubMed

Insights

Pseudomonas aeruginosa showed varying fluoroquinolone sensitivity, with norfloxacin and ciprofloxacin being most effective. Hospitalized patients had significantly higher rates of resistant strains compared to outpatients.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen frequently causing hospital-acquired infections.
  • Fluoroquinolones are a class of antibiotics commonly used to treat P. aeruginosa infections.
  • Understanding antibiotic resistance patterns is crucial for effective treatment strategies.

Purpose of the Study:

  • To analyze the sensitivity of Pseudomonas aeruginosa strains to various fluoroquinolones.
  • To compare antibiotic resistance between strains isolated from hospitalized and outpatient populations.

Main Methods:

  • Disk diffusion method was employed to test antibiotic sensitivity.
  • National Committee for Clinical Laboratory Standards (NCCLS) guidelines were followed.
  • 120 P. aeruginosa strains were analyzed, sourced from hospitalized (76) and outpatient (44) individuals.

Main Results:

  • Norfloxacin and ciprofloxacin demonstrated the highest sensitivity rates across tested strains.
  • None of the P. aeruginosa strains were sensitive to flumequine.
  • Antibiotic resistance was significantly higher in strains from hospitalized patients (51.3%) compared to outpatients (13.6%).

Conclusions:

  • Norfloxacin and ciprofloxacin are effective against a substantial proportion of P. aeruginosa strains.
  • Fluoroquinolone resistance is a significant concern, particularly in hospitalized patients.
  • Surveillance of antibiotic resistance patterns is essential for guiding clinical practice.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...